Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Shepp

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
The Journal of Infectious Diseases|January 1, 1993
Effect of didanosine on human immunodeficiency virus viremia and antigenemia in patients with advanced disease: correlation with clinical responseD H Shepp, A Ashraf
Dermatologic Clinics|April 1, 1997
Antiretroviral agents. Current usageM N Chaudry, D H Shepp
Oncology (Williston Park, N.Y.)|July 1, 1992
Herpes simplex virus infection in cancer patients: prevention and treatmentI T Tang, D H Shepp
The New England Journal of Medicine|January 23, 1986
Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabineD H Shepp, P S Dandliker, J D Meyers
The American Journal of Medicine|August 29, 1988
Current therapy of varicella zoster virus infection in immunocompromised patients. A comparison of acyclovir and vidarabineD H Shepp, P S Dandliker, J D Meyers
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 15, 1996
Seroepidemiology of cytomegalovirus in patients with advanced HIV disease: influence on disease expression and survivalD H Shepp, J E Moses, M H Kaplan
AIDS (London, England)|April 1, 1988
Human class I MHC-restricted cytotoxic T-lymphocytes specific for human immunodeficiency virus envelope antigensD H Shepp, F Daguillard, D Mann, et al.
Transplantation|June 1, 1984
Acyclovir treatment of varicella-zoster virus infection in the compromised hostJ D Meyers, J C Wade, D H Shepp, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1985
Once-daily intravenous acyclovir for prophylaxis of herpes simplex virus reactivation after marrow transplantationD H Shepp, P S Dandliker, N Flournoy, et al.
The Journal of Infectious Diseases|December 1, 1985
Comparative trial of ketoconazole and nystatin for prevention of fungal infection in neutropenic patients treated in a protective environmentD H Shepp, A Klosterman, M S Siegel, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Infectious Diseases|January 1, 1993
Effect of didanosine on human immunodeficiency virus viremia and antigenemia in patients with advanced disease: correlation with clinical responseD H Shepp, A Ashraf
Dermatologic Clinics|April 1, 1997
Antiretroviral agents. Current usageM N Chaudry, D H Shepp
Oncology (Williston Park, N.Y.)|July 1, 1992
Herpes simplex virus infection in cancer patients: prevention and treatmentI T Tang, D H Shepp
The New England Journal of Medicine|January 23, 1986
Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabineD H Shepp, P S Dandliker, J D Meyers
The American Journal of Medicine|August 29, 1988
Current therapy of varicella zoster virus infection in immunocompromised patients. A comparison of acyclovir and vidarabineD H Shepp, P S Dandliker, J D Meyers
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 15, 1996
Seroepidemiology of cytomegalovirus in patients with advanced HIV disease: influence on disease expression and survivalD H Shepp, J E Moses, M H Kaplan
AIDS (London, England)|April 1, 1988
Human class I MHC-restricted cytotoxic T-lymphocytes specific for human immunodeficiency virus envelope antigensD H Shepp, F Daguillard, D Mann, et al.
Transplantation|June 1, 1984
Acyclovir treatment of varicella-zoster virus infection in the compromised hostJ D Meyers, J C Wade, D H Shepp, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1985
Once-daily intravenous acyclovir for prophylaxis of herpes simplex virus reactivation after marrow transplantationD H Shepp, P S Dandliker, N Flournoy, et al.
The Journal of Infectious Diseases|December 1, 1985
Comparative trial of ketoconazole and nystatin for prevention of fungal infection in neutropenic patients treated in a protective environmentD H Shepp, A Klosterman, M S Siegel, et al.
Pageof 4